Peter Guzzo and Valentin Beuchillot will be heading to #BIOEurope in Cologne next week. Still a few openings left on the calendar! Reach out on the partnering platform or bd@variational.ai hubs.ly/Q04D1lw_0 #AIDD #AIDrugDiscovery #AIinPharma #GenAIinPharma #DrugDiscovery

Designing brain-penetrant ATR inhibitor is a hard problem; screening might not be the right way to solve it. Rakovina’s kt-5000AI program, built on Enki™, gets a live walkthrough Nov 5, 9:30 a.m. PT. #DrugDiscovery hubs.ly/Q04D3mQY0

Next week Handol Kim and Valentin Beuchillot are at Invest in BC 2026, hosted by Life Sciences BC and presented by Lumira Ventures, during Life Sciences Investment Week. Come meet with us!
#DrugDiscovery #GenerativeAI #AIDD #Biotech #VariationalAI #InvestInBC

We are in Seoul this week for BIOPLUS-INTERPHEX KOREA, with Canada as Country of Honour 🇰🇷 🇨🇦 Come find us at the Canadian Pavilion, or reach out at bd@variational.ai
📍 COEX, Seoul
🗓 October 28 to 30
#DrugDiscovery #GenerativeAI #AIDD #SmallMolecules #VariationalAI #BIX2026

Eight ATR inhibitors have entered the clinic. None is brain-penetrant. @rakovina_rkv designed kt-5000 with Enki™ to meet that profile: 122 compounds, ~2 years, ~US$1M direct external spend to candidate-ready. Full case study: hubs.ly/Q04B-nd00
#AIDD #DrugDiscovery

SK Life Science Labs selects our Enki™ platform for generative AI-driven lead discovery. We will deliver new lead series for an undisclosed SK LSL program: “a faster path to promising leads for challenging targets,” says CSO Ryan Kruger. #AIDD
hubs.ly/Q04BG7fj0

We’re in Seoul for BIX 2026 with the Canadian delegation, taking partnering meetings on AI-enabled lead generation and optimization all three days. Our CEO Handol Kim also moderates the Oct 30 panel on real value in AI drug discovery. #AIDD #DrugDiscovery hubs.ly/Q04BdqTr0

Don't miss our CEO, Handol Kim, on BC Tech's Scaleup Academy panel "BC's HealthTech AI Advantage" this Wednesday, Oct 7, 11am PT, online.
hubs.ly/Q04zbLtr0

Come meet with @VariationalAI this week at Discovery on Target Boston! Valentin Beuchillot and Peter Guzzo present the poster C099: novel PRMT6 inhibitors via AI-driven design and synthesis. #AIDD #DrugDiscovery #BostonDOT
hubs.ly/Q04yM8Lx0

Canada isn't short on AI research 🇨🇦 Thank you, @wearebctech for naming Variational AI a 2026 Technology Impact Awards finalist: Gamechanger - AI and Company of the Year - Growth. 📍Join the Gala on Oct 29, at Parq Vancouver.
hubs.ly/Q04ydY-80
#2026TIAs #AIDD #GenAI #AI

Hard targets get easier with better starting chemistry! Next week at Discovery on Target Boston (Sept 28-Oct 1), Peter Guzzo presents poster C099: novel PRMT6 inhibitors via AI-driven design and synthesis. #AIDD #DrugDiscovery #BostonDOT
hubs.ly/Q04xZ-Wd0

#ALLIN2026 wrapped in Montréal 🇨🇦

Thanks to @ScaleAICanada for the great organization and for bringing the AI Canadian community together!

#GenerativeAI #AI #GenAI #VariationalAI

@VariationalAI on the road! Our Co-Founder & CEO is traveling to two Canadian stages next week. @BIOTECanada #BIONATION2026 in Ottawa on Sept. 22 and the @Bioalberta #HLSS2026 in Calgary on Sept 24. 🇨🇦 #AIDD hubs.ly/Q04xsXxW0 #AIDrugDiscovery #GenAIinPharma

At #BostonDOT, Peter Guzzo, our EVP of Drug Discovery, will present a new poster: "Initial Efforts to Discover Novel PRMT6 Inhibitors via AI-Driven Design and Synthesis" detailing the work of our collaboration with @AgoraOpenSci and @EnamineLtd #AIDD
hubs.ly/Q04w_0mZ0

Variational AI is in Montréal next week for ALL IN 2026, Sept 16 and 17. Send us a meeting request on the event app to talk #GenerativeAI in early-stage #DrugDiscovery. Our CEO Handol Kim is also on the Thursday plenary panel, Forum Stage, 3pm ET.
hubs.ly/Q04wYT9T0

Canada builds world-class AI companies. Scaling them globally is rarely a technology problem. Our CEO Handol Kim joins the ALL IN plenary on building Canadian AI champions. Forum Stage, Thu Sept 17, 3pm ET, Montreal. #GenerativeAI #Biotech hubs.ly/Q04w6C470

Our CEO Handol Kim joins the first episode of The Future of Life Sciences series, presented by Merck Canada, on how #GenerativeAI like Enki™ is reshaping #DrugDiscovery in Canada. Watch 🔗 hubs.ly/Q04pH7Bz0 #AIDD #AIinPharma

Tomorrow, our Co-Founder & CTO Jason Rolfe keynotes at UBC on how foundation models are reshaping #DrugDiscovery.
📍Gordon B. Shrum Bldg
🗓July 10, 12pm PDT.
hubs.ly/Q04n-_PB0
All welcome, no registration. #AIDD #GenerativeAI

Want to work where ML meets medicinal chemistry? Variational AI is #hiring across the team as we scale Enki™ for #DrugDiscovery. See every open position → hubs.ly/Q04nJsmS0 #AIDD

At last week's @CCG_MOE North American UGM in Montreal, Alex Perryman showed how Enki™ outputs, docked against a novel PRMT6 allosteric site and analyzed in MOE, produced a novel-scaffold hit in under 3 months. #DrugDiscovery #GenerativeAI #GenAIinPharma #AIDD #CompChem

"No cooler mission exists than developing medicines to help patients." Our CEO Handol Kim, featured by #AWSCanada in their AI Innovators series. See how Enki™ uses #GenerativeAI to make #DrugDiscovery ~100x more efficient 🇨🇦
hubs.ly/Q04mZl5Z0
#AIDD #GenAIinPharma

Yesterday our CTO Jason Rolfe joined @Invest_Van's panel "From Intelligence to Industry" on what turns Vancouver's #AI research into real companies. Thanks to everyone who attended #GenerativeAI #GenAIinPharma #AIDD #Vancouver #BCTech

Our team at BIO 2026 in San Diego this week, meeting with partners exploring generative AI for early-stage discovery!
#BIO2026 #AIDD #DrugDiscovery #GenerativeAI #SmallMolecules #VariationalAI

Vancouver is hosting the world this summer, and the tech scene is having its moment too. Our CTO Jason Rolfe joins Invest Vancouver's "From Intelligence to Industry" panel on June 23 at BC Business House. More info: hubs.ly/Q04lFMF90
#VanTech #InvestVancouver #AI #DeepTech

Heading to the CCG UGM in Montreal? Alex Perryman will present on June 25 on #SBDD & #GenerativeAI across (pre)clinical oncology programs. Don't miss it!
hubs.ly/Q04lv95L0
#AIDD #DrugDiscovery #GenAIinPharma

🎉 Variational AI is a 2026 @wearebctech - Technology Impact Award finalist in two categories: Gamechanger - AI and Company of the Year - Growth.
Recognition for how Enki™ rethinks early #DrugDiscovery. Winners announced this Fall at the #2026TIAs Gala.
#AIDD #GenerativeAI

Variational AI is heading to Paris for #VivaTech, June 17-20, as part of the @ScaleAICanada Canadian delegation. Handol Kim will be on the ground talking generative AI for early-stage drug discovery.
hubs.ly/Q04kDjM60

Tomorrow, our CEO Handol Kim closes the #BCTech Annual Member Summit with "Where Health meets AI," on how #VariationalAI applies #GenerativeAI to design novel drug candidates and shorten early discovery.
📍 Terminal City Club, Vancouver, 4:25 PM! bd@variational.ai to connect.

With Enki™ 4, our #GenerativeAI now designs beyond small molecules, and can be applied to proximity-based therapeutics: #PROTACs, #MolecularGlues, #Degraders, #ADC payloads. Meet us at #BIO2026 in San Diego. Request on the platform or bd@variational.ai
#DrugDiscovery #AIDD

Variational AI will be at #BIO2026, San Diego, June 22-25.
Scoping an early-stage program where #GenerativeAI could speed up multi-property optimization? Let's talk!
Book a meeting using the platform or via email at bd@variational.ai
hubs.ly/Q04hQjzg0
#AIDD #GenAIinPharma

Enki 4 launched last month with 760 pre-trained drug targets. We're now at 873!
Check if yours is covered and explore starting a program: hubs.ly/Q04hPz3n0
#AIDD #DrugDiscovery #AIinPharma #GenerativeAI #SmallMolecules #VariationalAI #GenAIinPharma

@VariationalAI is hiring a Chemical Data Scientist! Curate datasets across potency, ADMET, gene expression, etc.... Build featurizations that feed Enki™. Vancouver or remote in Canada. hubs.ly/Q04gTf6P0 #AIDD #Hiring #Cheminformatics #DataScience

@VariationalAI and 3C Therapeutics are launching a research collaboration to design next-generation Degrader Antibody Conjugates (DACs), with support from Innovate BC's Integrated Marketplace program.
Full release 👉
hubs.ly/Q04gT75Q0

"The new unit economics of drug discovery" at #WebSummit yesterday: Handol Kim, Ricardo Baptista Leite (HealthAI), and Jennifer Strong (SHIFT Podcast) on how AI shifts pharma from massive libraries to targeted molecular design, and what regulators need to do next. #AIDD

At #WebSummit Vancouver this week? Find us at Booth G1-09 today only to talk about our generative AI platform for early-stage small molecule discovery. #GenerativeAI #AIDD

Variational AI is hiring across ML, Chemistry and Project Mgt. Vancouver or remote in N Am. Real science! hubs.ly/Q04dB_xZ0
#AIDD #Hiring #NowHiring #DrugDiscovery #ComputationalChemistry #MachineLearning

Today at Boston PBSS, our CTO Jason Rolfe is speaking about generative molecular design, and specifically how starting from better chemical space leads to better leads with fewer DMTA cycles. How it works? hubs.ly/Q04dBY2Q0
#AIDD #DrugDiscovery #PBSS

Heading to @WebSummit Vancouver. Meet us at our booth on May 12, and catch Handol Kim on the AI Summit stage on May 13 for "The new unit economics of drug discovery." hubs.ly/Q04ddXHs0 #GenerativeAI #WebSummitVancouver #AIDD #DrugDiscovery

6 open roles at Variational AI across ML, computational chemistry, and drug discovery project management. Vancouver or Remote in N Am. Full-time. Real science! 🚀
hubs.ly/Q04cNlx40
#AIDD #Hiring #NowHiring #DrugDiscovery #ComputationalChemistry #MachineLearning

Most #DrugDiscovery programs optimize within known chemical space. What happens when you can explore beyond it? Jason Rolfe makes the case at #PBSS Cambridge, on April 28. 👉 Interested? Register here: hubs.ly/Q04bGzh20
#AIDD #GenerativeAI

Today at ALL IN Talks West, Variational AI CEO Handol Kim speaks on closing the gap between #AI research and real-world impact, using #DrugDiscovery as the proving ground.
🔗 hubs.ly/Q04c8TqC0
#GenerativeAI #AIDD

DDC 2026, San Diego, this week. Find Brian Atwood from @VariationalAI to discuss how #GenerativeAI fits into your early #SmallMolecule discovery workflow.
🔗 hubs.ly/Q04bGkP20
or ✉️ bd@variational.ai
#DDC2026 #AIDD #GenAIinPharma

"Our goal is to eliminate hit ID and hit-to-lead, generating molecules ready to go directly into lead optimization." — Handol Kim, Co-Founder & CEO
Enki™ 4 is live - hubs.ly/Q049L3SY0

#AIDD #DrugDiscovery #GenerativeAI #GenAIinPharma #Enki4 #VariationalAI

We just released Enki™ 4 🚀
760 pre-trained targets, 12+ target classes, and new coverage for degraders, PROTACs, and ADC payloads. Our Goal? Eliminating hit ID and hit-to-lead! hubs.ly/Q049KZrK0
#Enki4 #AIDD #GenerativeAI #VariationalAI #GenAIinPharma #DrugDiscovery

A busy month ahead for the Variational AI team!
3️⃣ Weeks
4️⃣ Cities
5️⃣ Events
Find us there 👉 hubs.ly/Q048WBxq0
#DDC2026 #ALLINTalks #BBHIC2026 #MaRSImpactHealth #AIDD #DrugDiscovery #GenerativeAI #VariationalAI

6 open roles at Variational AI 🚀 Spanning across ML, computational chemistry, and drug discovery project management. Vancouver or Remote in N Am. Full-time. Real science!
hubs.ly/Q048WjdG0
#AIDD #Hiring #NowHiring #DrugDiscovery #ComputationalChemistry #MachineLearning

Attending #DDC2026 in San Diego (Apr 13-16)? Brian Atwood from our team will be there. Reach out at bd@variational.ai to talk generative molecular design and #AIDD.
hubs.ly/Q048vrTM0

🤝 @EnamineLtd joins @VariationalAI & @AgoraOpenSci to accelerate #PRMT6 inhibitor discovery for #SBMA, a rare neuromuscular disease with no approved treatments. Enki designs constrained to Enamine REAL Space for rapid, open #DrugDiscovery.
🔗hubs.ly/Q0485W7K0

We’re hiring 🚀 - 2 new roles at Variational AI:
• Project Management (Drug Discovery)
• Machine Learning Software Engineer
Apply: hubs.ly/Q047sTyL0

#Hiring #DrugDiscovery #MachineLearning #AIDD #jobs

What’s changing in early-stage drug discovery?

Moving from discriminative models to generative models to expand how research teams explore the chemical space and reduce dependence on predefined libraries.

Read more: hubs.ly/Q0478YxJ0

#DrugDiscovery #GenerativeAI #AIDD

Catch the Variational AI team on the road in April 🌎

• #DrugDiscoveryChemistry 2026
• #ALLINTalksWest
• #BBHIC2026
• MaRS Impact Health Summit
• PBSS AI & ML in Drug Discovery

Let’s connect 👇
hubs.ly/Q046t1bH0

#DrugDiscovery #GenerativeAI #AIDD

Missed our webinar with @rakovina_rkv on how #GenerativeAI helped design brain-penetrant ATR/mTOR inhibitor candidates?
Hear how Enki™ supported the design → synthesis → validation workflow and what early preclinical readouts suggest.
hubs.ly/Q0462Z-K0
#AIDD #AIinPharma

📢 “Bigger Leaps, Better Leads” - Don't miss Jason Rolfe's talk at the upcoming #PBSS symposium in Boston! Our CTO will explore how #GenerativeAI helps expand the frontier of #SmallMolecule #DrugDiscovery
Apr 28 | 10:55–11:45 AM
Register: hubs.ly/Q045G8jJ0

#AIDD #GenAI

Join Variational AI 🚀 We’re building #AI models to solve #DrugDiscovery and we need your #ML and #ComputationalChemistry expertise in multiple roles!
Apply 👉 hubs.ly/Q045d1d30
#Hiring #Careers #MLJobs #CompChem

Great energy at the 11th Annual Access to Innovation 🚀 A strong reminder of how vibrant BC’s life sciences ecosystem has become!
Thanks @lifesciences_bc for hosting!
#AIDD #GenAIinPharma

Is more data always better in #AIDD?
At the AI Convergence Small Molecule Discovery Summit our CEO, Handol Kim, will challenge the “more data = better models” assumption! Join the discussion: Mar 20, 2026 | 9:30 AM
hubs.ly/Q044gxGh0
#DrugDiscovery #GenerativeAI #AIinPharma

@VariationalAI is heading to @lifesciences_bc’s 11th Annual Access to Innovation. Handol Kim will deliver a keynote: “AI for drug discovery is happening now. Are you ready?” More details and registration: hubs.ly/Q043qcg80
#DrugDiscovery #GenerativeAI #AIDD #SmallMolecule

@VariationalAI is heading to @lifesciences_bc’s 11th Annual Access to Innovation. Handol Kim will deliver a keynote! Looking forward to discuss how AI is impacting the Life Sciences sector. More info: hubs.ly/Q042mhtK0
#DrugDiscovery #GenerativeAI

Work at the intersection of #GenerativeAI and early-stage #DrugDiscovery—building models chemists trust to explore drug-like chemical space and move faster toward preclinical candidates.
Apply 👉 hubs.ly/Q0428wDM0
#Hiring #MachineLearning #ComputationalChemistry

Handol Kim, will be presenting at the AI Convergence: Small Molecule Discovery Summit (Mar 18–20, 2026 | Boston).
Looking forward to engaging with peers on how #AI can accelerate small-molecule #discovery from molecule to market.
🔗 hubs.ly/Q041n0Hv0
#AIDD #GenerativeAI

📅 One week to go until the 2026 OBIO® Investment Summit in Toronto 🇨🇦
Handol Kim will be on site meeting investors, pharma, and ecosystem partners across life sciences & health tech.
Let’s connect 👉 hubs.ly/Q040mWnq0

#OBIO #OIS2026 #AIDD #GenAIinPharma #GenerativeAI

Work at the intersection of #GenerativeAI and early-stage #DrugDiscovery—building models chemists trust to explore drug-like chemical space and move faster toward preclinical candidates.
Apply 👉 hubs.ly/Q040mPR-0
#Hiring #MachineLearning #ComputationalChemistry

We’re heading to Toronto for the 2026 #OBIOInvestmentSummit 🇨🇦
Our CEO & Co-founder Handol Kim will be on site connecting with investors, pharma and partners shaping life sciences & health tech.
Let’s connect 👉 hubs.ly/Q03_QwQ00

#OBIO #OIS2026 #AIDD #GenAIinPharma

In case you missed it over the holidays 🎄 | Our @rakovina_rkv x @VariationalAI fireside chat is now on demand.
🎥 Watch: hubs.ly/Q03_pL-90
#DrugDiscovery #Oncology #MedChem #AIinBiotech

JPM Week in San Francisco is a wrap.
Great conversations with biotech, pharma & investors on how #GenerativeAI can support early-stage #DrugDiscovery in practical, chemistry-grounded ways.
If we missed you in SF, happy to continue the conversation. #JPMWeek26

Join Variational AI 🚀 We’re redefining the unit economics of #DrugDiscovery for better patient outcomes. Open roles:
- Applied #ML Scientist
- ML Scientist
- Computational Chemist
- Cheminformatician
Apply now 👉 hubs.ly/Q03-gYyJ0
#Hiring #Careers #MLJobs #CompChem

Variational AI is in San Francisco for #JPMWeek26.
We’ll be at the Biotech Showcase and active on BIO Partnering this week.
Exploring #AIDD for early-stage #DrugDiscovery? Let’s connect!

We are expanding our collaboration with @rakovina_rkv to optimize the kt-5000 ATR inhibitor program. Enki™ will be applied to iteratively refine AI-designed leads, aiming to reach a clinical candidate faster.
🔗 hubs.ly/Q03-3qYt0
#DrugDiscovery #AIDD #AIinPharma

Handol Kim is presenting Variational AI at the #TechBioShowcase in San Francisco.
🗓 Jan 12 | ⏰ 9:45 AM
📍 Hilton Hotel — Franciscan C (Ballroom Level)
Can’t make it? Book a 1:1 meeting 👉 hubs.ly/Q03ZzjrD0
#GenAIinPharma #DrugDiscovery #GenerativeAI

Happy New Year from the Variational AI team 🎉
Wishing you a successful year ahead! We’re looking forward to what 2026 will bring 🙌

JPM is in two weeks. If you’re looking for new leads or optimized molecules for your discovery programs, let’s connect. Our team will be onsite to discuss how generative AI supports early small-molecule design
📩 bd@variational.ai
#JPMWEEK26 #JPM2026 #DrugDiscovery #GenerativeAI

Happy holidays from the Variational AI team 🎄 Thanks to our customers, partners, collaborators, and the drug discovery community for the trust and thoughtful conversations this year; and to our team for powering everything we do. #AIDD #GenAIinPharma #DrugDiscovery

Join Variational AI 🚀 We’re redefining the unit economics of #DrugDiscovery for better patient outcomes. Open roles:
- #MLEngineer
- #MLScientist
- #ComputationalChemist.
Apply now 👉 hubs.ly/Q03YbvX60
#Hiring #Careers #AIjobs #MLJobs #CompChem

📆 Tomorrow (Dec 17) we’ll be live with @rakovina_rkv on how deep biology + #GenerativeAI are enabling #CNS-penetrant cancer therapies.
Hear how Enki™ helped design a CNS-penetrant ATR/mTOR inhibitor.
Register to join the live Q&A 👉hubs.ly/Q03YkdsM0
#GenAIinPharma #AIDD

@VariationalAI will be in San Francisco for #JPMWeek this January. We’ll be meeting biotech & pharma teams to discuss how #GenerativeAI can accelerate their early #SmallMolecule discovery programs.
Let’s connect 👉 hubs.ly/Q03XlpBd0
#DrugDiscovery #GenAIinPharma

🎙️Fireside chat on Dec 17! @rakovina_rkv & @VariationalAI share how deep biology and #GenerativeAI tackled CNS-penetrant ATR/mTOR inhibitors design and how the team moved from in-silico proposals to lab data.
Register: hubs.ly/Q03XvGfg0
#DrugDiscovery #GenAIinPharma

We’re hiring a #MachineLearning Scientist to ship new #ML models (diffusion, Transformers, uncertainty quantification, Bayesian optimization)
Build real models with real impact—no chemistry background required.
Apply here 👉 hubs.ly/Q03WLBQz0
#AIDD #Hiring #MLjobs #AIjobs

At #SNO2025, @rakovina_rkv shared preclinical data on Enki-designed ATR/mTOR inhibitors with CNS penetration vs current ATR inhibitors. Read the latest update on the project: hubs.ly/Q03W3jxk0
#DrugDiscovery #GenerativeAI #AIDD #SmallMolecule

Our CEO, Handol Kim, will speak at the "AI Convergence: Small Molecule Discovery Summit" | March 18–20, 2026, in Boston. Join the event: hubs.ly/Q03V99gb0
#DrugDiscovery #GenerativeAI #AIinPharma

We’re #hiring a #ComputationalChemist (Vancouver or remote)!
Apply your docking & MD skills to advance AI-driven small-molecule discovery. PhD | 2+ yrs industry exp.
🔗 hubs.ly/Q03STRt10
#ComputationalChemistry #AIDD #CompChem #sciencejob

Team @VariationalAI is at BIO Europe in Vienna 🇦🇹!
Pete Guzzo & Valentin Beuchillot are meeting biotechs and pharmas to discuss how #GenerativeAI accelerates early-stage #DrugDiscovery.
Let’s connect if you’re here!

We took home the @BIOTECanada Award at the LSBCinvest event, presented by @LumiraVentures.
Our CTO, Jason Rolfe showcased Enki, our #GenerativeAI platform for small molecule #DrugDiscovery, highlighting how it can transform early stages of R&D.
🔗 hubs.ly/Q03QGdFD0

Heading to #BIOEurope in Vienna? 🇦🇹
Our @VariationalAI team — Peter Guzzo & Valentin Beuchillot — will be there to discuss how #AIDD is reshaping small molecule #DrugDiscovery.
Let’s meet up 👋
🔗 hubs.ly/Q03PqggL0

BC’s innovation ecosystem turns deep research into global impact — and we’re proud to be part of it.
Thanks @BCTradeInvest for highlighting our #GenerativeAI work in #smallmolecule #DrugDiscovery.
🔗 hubs.ly/Q03PqlVX0

From 12,000+ startups to just 50 - @VariationalAI joins @CBinsights’ 2025 #DigitalHealth50 🎉

Grateful to see our #GenerativeAI for #DrugDiscovery recognized among the innovators shaping the future of #TechBio.
🔗 hubs.ly/Q03PPDf60

We’re heading to Frontiers Health event (#FH25) in Berlin 🇩🇪!
@VariationalAI joins “From Molecule to Market,” a masterclass with 7 Canadian AI innovators 🇨🇦 — in partnership with the Canadian Trade Commissioner Service.
🗓️ Nov 11 | 2:30–4:00 PM CET
🔗 hubs.ly/Q03PnwMY0

We’re joining the 10th Annual #LSBCInvest — connecting top innovators, investors & leaders shaping BC’s #Biotech and #Pharma future. Don’t miss your chance — limited spots left! 🔗 hubs.ly/Q03NZcf00

#GenerativeAI #DrugDiscovery #AIDD #Innovation

Our collaboration with Merck (MSD) shows what’s possible with Enki™.
Contact bd@variational.ai to try it now! Learn more about the collaboration: hubs.ly/Q03Np14s0
#DrugDiscovery #GenerativeAI #AIinPharma #AIDD

We’re in Yokohama for #BioJapan 2025 as part of the 🇨🇦 #DeepTechCanada delegation!
Great discussions on how our #GenerativeAI platform is reshaping #SmallMolecule #DrugDiscovery.
See where to meet us next 👉 hubs.ly/Q03MTwN90

Attending #BIOEurope? If you’re in #SmallMolecule #DrugDiscovery or starting a new program, @VariationalAI can help you identify new Leads with generative AI.
Let’s connect on the partnering platform 🔗 hubs.ly/Q03MfzPd0

Yesterday at the @lifesciences_bc awards ceremony, @VariationalAI received the recognition of being the Emerging Company of the Year 🎉

hubs.ly/Q03M7SK70

Team Variational AI is heading to Yokohama next week for the BioJapan 🇯🇵 Reach bd@variational.ai to meet about #GenerativeAI enhancing #SmallMolecule #DrugDiscovery!
#AIDD #BioJapan2025

$349M potential deal value!
That’s the scale of our collaboration with Merck (MSD), announced last week.
Read more 👉 hubs.ly/Q03LnrmM0
#GenerativeAI #DrugDiscovery #AIinPharma #Biotech #Pharma #AIDD

We’re excited to announce a new #collaboration with @Merck (MSD). We will apply our Enki™ platform, fine-tuned on Merck’s proprietary data, to generate and optimize novel #smallmolecule candidates. Read the PR 👉 hubs.ly/Q03Ktg7H0
#GenerativeAI #AIinPharma #AIDD

Heading to Discovery on Target? Don’t miss Peter Guzzo presenting our poster showcasing our collaboration with @Life_Chemicals using #GenerativeAI to identify selective dual EGFR/FGFR1 inhibitors. Reach bd@variational.ai to connect! #BostonDOT25 #AIinPharma #DrugDiscovery

Variational AI is heading to Vienna 🇦🇹 for #BIOEurope 2025! Nov 3–5, we’ll join 5,700+ global biotech & pharma leaders to discuss #GenerativeAI in #DrugDiscovery. Let’s connect: bd@variational.ai
#AIDD

Designing selective dual inhibitors is a real challenge! We are partnering with @Life_Chemicals and used #GenerativeAI to design novel EGFR/FGFR1 inhibitors. Read more: hubs.ly/Q03JTwYt0
#DrugDiscovery #AIinPharma #SmallMolecules #AIDD